MG
GMED icon

Mather Group’s Globus Medical GMED Stock Holding History

Mather Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.3K Buy
+305
New +$27.4K ﹤0.01% 1217
2025
Q4 		– Sell
-395
Closed -$22.6K – 1041
2025
Q3 		$22.6K Buy
+395
New +$22.7K ﹤0.01% 1091
2025
Q2 		– Sell
-1,417
Closed -$104K – 1051
2025
Q1 		$104K Buy
1,417
+61
+4% +$5.04K ﹤0.01% 740
2024
Q4 		$112K Buy
1,356
+190
+16% +$15K ﹤0.01% 711
2024
Q3 		$83.4K Sell
1,166
-165
-12% -$11.6K ﹤0.01% 776
2024
Q2 		$71.4K Buy
1,331
+34
+3% +$2.03K ﹤0.01% 908
2024
Q1 		$69.1K Buy
+1,297
New +$69.7K ﹤0.01% 802

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mather Group's GMED Position: Q1 2026 in Review

Mather Group opened a new position in Globus Medical (GMED) in Q1 2026: 305 shares worth $26.3K. The stake represents ﹤0.01% of the portfolio and ranks #1217 among its holdings. This is a return to the name: Mather Group previously reported a position in GMED as recently as Q3 2025.

Mather Group first reported a position in GMED in Q1 2024 and has held it in 7 quarters since. The position peaked at $112K in Q4 2024. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Mather Group held 305 shares of Globus Medical worth $26.3K as of Q1 2026.
  • Globus Medical was a new Mather Group position in Q1 2026.
  • Globus Medical made up ﹤0.01% of Mather Group's portfolio in Q1 2026, its #1217 holding.
  • Mather Group first reported a position in Globus Medical in Q1 2024 and has held it in 7 quarters since.
  • Mather Group's Globus Medical position peaked at $112K in Q4 2024.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.